Claudia Brewer Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 347 The Hills Dr, The Hills, TX 78738 Phone: 512-330-4149 |
News Archive
The University of Colorado Cancer Center and Loxo Oncology, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief in the online edition of the journal Cancer Discovery, describing the first patient with a tropomyosin receptor kinase fusion cancer enrolled in the Phase 1 dose escalation trial of LOXO-101, the only selective TRK inhibitor in clinical development.
Vexim, the specialist in minimally invasive anatomical restoration of vertebral compression fractures, today announced the CE Marking and the market launch of its 6.5 mm diameter SpineJack implant, which thus guarantees the technology's compliance and safety.
Karyopharm Therapeutics Inc., a leader in the new field of nuclear transport modulators, announced dosing of patients in the first-in-human clinical trials with KPT-330.
A new variety of long-lasting insulin, called insulin degludec, lowers the risk of nighttime low blood sugar in elderly diabetic adults compared with insulin glargine, a systematic review of diabetes studies has found.
A study led by Indiana University biologist Patricia Foster and colleagues has found that forces in the external environment and oxidation are the greatest threats to an organism's ability to repair damage to its own DNA.
› Verified 5 days ago